![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 45, 35070-35076, November 10, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Molecular Biology Program, Sloan-Kettering Institute,
New York, New York 10021
Received for publication, June 30, 2000, and in revised form, August 15, 2000
Baculovirus phosphatase (BVP) is a member of the
metazoan RNA triphosphatase enzyme family that includes the RNA
triphosphatase component of the mRNA capping apparatus. BVP and
other metazoan RNA triphosphatases belong to a superfamily of
phosphatases that act via the formation and hydrolysis of a covalent
cysteinyl-phosphate intermediate. Here we demonstrate the formation of
a BVP phosphoenzyme upon reaction with [ RNA triphosphatase catalyzes the hydrolysis of the The metazoan RNA triphosphatases are subdivided into two groups: (i)
bifunctional enzymes composed of an N-terminal RNA triphosphatase domain and a C-terminal RNA guanylyltransferase domain (1-9) and (ii)
monofunctional RNA triphosphatases (10-12). The bifunctional enzymes
are ubiquitous in higher eukaryotes, where they are responsible for
forming the 5' cap structure of cellular mRNAs. The monofunctional enzymes perform RNA 5' modification reactions uncoupled from or unrelated to cap formation, and their true role in RNA metabolism is
not understood. The latter category includes
BVP,1 a phosphatase encoded
by the Autographa californica baculovirus (10, 11), and the
human PIR1 phosphatase (12). Also in the latter category are the
alternatively spliced forms of the cellular capping enzymes that retain
the RNA triphosphatase domain but lack essential constituents of the
guanylyltransferase active site (7-9).
The RNA triphosphatase domains of the metazoan and plant capping
enzymes contain the signature HCXXGXXR(S/T)
phosphate-binding motif of the protein-tyrosine phosphatase/dual
specificity protein phosphatase enzyme superfamily (Fig. 1).
Protein-tyrosine phosphatases and dual specificity protein phosphatases
catalyze the dephosphorylation of phosphoproteins via a two-step
pathway (21, 22). First, a cysteine thiolate nucleophile of the enzyme
attacks the phosphomonoester (R-O-PO3) to form a covalent
protein-cysteinyl-S-phosphate intermediate and liberate R-OH
(Fig. 1). Then, the covalent intermediate is hydrolyzed to liberate
inorganic phosphate. The cysteine within the signature motif is the
active site of phosphoryl transfer by protein phosphatases. The attack
of cysteine on a phosphomonoester to form the phosphoenzyme is driven
by two principal enzymic catalysts: (i) a conserved arginine in the
phosphate-binding motif that makes a bidentate interaction with the
nonbridging phosphate oxygens and thereby stabilizes the transition
state, and (ii) a conserved aspartate, which is protonated in the
ground state and acts as a general acid to expel the leaving group
oxygen. The general acid is located within a flexible loop element that
is distant from the active site pocket when the enzyme is in the
unliganded state and moves into the active site upon binding of
substrate or substrate analog (23-26). A mechanism of regulation of
protein phosphatases through the flexible general acid loop, either
positively by promoting closure of the loop or negatively by hindering
its mobility, has been discussed (26).
Although several groups have reported that mutation of the active-site
cysteine of metazoan RNA triphosphatases to alanine or serine abolishes
RNA triphosphatase activity in vitro and in vivo
(1, 4, 6, 10, 11), there is as yet no direct evidence for the formation
of a phosphoenzyme during the RNA triphosphatase reaction.
Here we probe the catalytic mechanism of the baculovirus RNA
triphosphatase BVP. The 168-amino acid BVP protein displays extensive sequence similarity to the triphosphatase domains of metazoan and plant
capping enzymes. The similarity embraces the cysteine-containing signature motif and a single conserved aspartic acid (Fig.
1). Purified recombinant BVP hydrolyzes
the We demonstrate here the formation of a covalent phosphoenzyme adduct
during the reaction of BVP with [ Missense Mutants of BVP--
Plasmid pET16-BVP encodes the
168-amino acid BVP polypeptide fused to an N-terminal leader peptide
containing 10 tandem histidines (10). Expression of the protein is
under the control of a T7 RNA polymerase promoter. Missense mutations
and "silent" diagnostic restriction sites were introduced into the
BVP gene by polymerase chain reaction using the two-stage overlap
extension method (39). pET16-BVP was used as the template for the
first-stage amplifications. The mutated DNA products of the
second-stage amplification were digested with NdeI and
BamHI and inserted into pET16b. The presence of the desired
mutations was confirmed by DNA sequencing; the inserted restriction
fragments were sequenced completely in order to exclude acquisition of
unwanted mutations during amplification and cloning.
Expression and Purification of Recombinant BVP--
The
wild-type and mutated pET16-BVP plasmids were transformed into
Escherichia coli BL21. BVP expression was induced by
infection of the cells with Determination of BVP Protein Concentration--
Aliquots
of each phosphocellulose BVP preparation were analyzed by SDS-PAGE in
parallel with 1, 2, 3, and 4 µg of bovine serum albumin. The gels
were fixed and stained with Coomassie Blue dye. The staining intensity
of the polypeptides was quantitated with a Digital Imaging and Analysis
System (Alpha Innotech Corp.). BVP concentrations were calculated by
extrapolation to the bovine serum albumin standard curve.
Detection and Chemical Stability of a BVP Phosphoenzyme--
A
reaction mixture containing 50 mM Tris acetate (pH 5.5), 1 mM DTT, 3 µM BVP, and 20 µM
[ ATPase Assay--
Reaction mixtures (10 µl) containing 50 mM Tris-HCl (pH 7.5), 1 mM DTT, 100 µM [ Formation of a Covalent Phosphoenzyme Adduct during the Reaction of
BVP with ATP--
Although hydrolysis of the Evidence for a Thiophosphate Adduct--
The SDS-denatured
[32P]BVP adduct was stable to 30 min exposure at 37 °C
to 0.1 M NaOH, or to 1 M hydroxylamine at pH
7.0, but the 32P was released quantitatively from the BVP
by 1 mM iodine at pH 7.0 (Fig.
3A). Stability to neutral
hydroxylamine argues against an acylphosphate linkage, whereas
hydrolysis by iodine is strongly indicative of a thiophosphate linkage,
presumably to Cys119. A control experiment showed that the
phosphoramidate linkage of [32P]GMP to Lys260
of vaccinia virus capping enzyme was unaffected by treatment with 1 mM iodine (data not shown).
The stability of the denatured BVP phosphoenzyme as a function of pH is
shown in Fig. 3B. The adduct was alkaline-stable, as noted
above, but relatively labile from pH 2 to pH 5. Stability was restored
at pH 0 to 1. This trough-like pH stability profile is characteristic
of a thiophosphate linkage (29) and has been described previously for
the phosphoenzyme of a mammalian protein-tyrosine phosphatase (27).
Mutational Analysis of the Phosphate-binding Loop--
Alanine
mutations were introduced in lieu of seven individual amino acids
within the conserved phosphate-binding motif of BVP
(117VHCTHGINRTGY128). The residues mutated were
His118, Thr120, His121,
Asn124, Arg125, Thr126, and
Tyr128. Wild-type BVP and the BVP-Ala mutants were
expressed in bacteria as His-tagged fusions and purified from soluble
bacterial lysates by nickel-agarose and phosphocellulose column
chromatography. SDS-PAGE analysis showed that the phosphocellulose
preparations were highly enriched with respect to the ~24-kDa BVP
polypeptide and that the extents of purification were similar (Fig.
4A). Recombinant wild-type BVP
catalyzed the release of 32Pi from
[
Mutants H118A, H121A, N124A, R125A, T126A, and Y128A were effectively
inert in ATP hydrolysis at a level of sensitivity of <0.1% of the
wild-type specific activity. These mutational effects were similar to
that of the C119A mutation (10). The T120A mutant was 7% as active as
wild-type BVP. Thus, all of the non-aliphatic side chains of the
phosphate-binding loop were important for activity.
Alanine substitution eliminated the side chain beyond the
The C119V and C119S proteins were catalytically inert. The failure to
restore activity by introducing an isosteric hydroxyamino acid in lieu
of cysteine underscored the strict requirement for a thiolate as the
reactive nucleophile.
Distinct conservative mutational effects were noted at the two
threonine positions of the phosphate-binding loop, Thr120
and Thr126. The ATPase activity was fully restored when a
valine was introduced at Thr120; indeed, the T120V mutant
was twice as active as wild-type BVP. Valine is nearly isosteric to
threonine, but lacks the potential for hydrogen bonding. Placing a
serine at position 120 only partially restored activity,
i.e. to 26% of the wild-type value, compared with 7% of
wild-type activity for the T120A mutant. Given that hydrogen bonding by
the hydroxyl was clearly not important, we suspect that the salutary
effects of serine at position 120 reflected occupancy by O
Asn124 was replaced conservatively by glutamine and
aspartic acid. The N124Q and N124D mutants were as defective in ATP
hydrolysis as N124A. These findings suggested that the essential
function of Asn124 entails hydrogen bonding interactions
with the amide moiety that are sensitive to its distance from the main chain.
His118 was changed to valine and asparagine. The H118V and
H118N proteins were just as defective as H118A. His121 was
mutated to glutamine and asparagine. H121Q was 2% as active as wild
type BVP, whereas H121N was 8% as active. Asparagine and glutamine are
partially isosteric with histidine, such that the amide nitrogens of
Asn and Gln can be imposed on N
Arg125 is conserved in all members of the cysteine
phosphatase superfamily. A lysine in lieu of arginine restored
phosphohydrolase activity to 10% of the wild-type level. This result
suggested that: (i) the positive charge on the side chain is essential
for function and (ii) bidentate interactions of the arginine side chain
contribute an additional order of magnitude to catalysis.
The essential Tyr128 side chain was substituted by
phenylalanine and leucine. The Y128F protein was fully active, whereas
Y128L was about one-third as active as wild-type BVP. Thus, neither a
hydroxyl group nor an aromatic group was strictly essential at this
position; rather, a bulky aliphatic side chain sufficed for BVP function.
Mutational Effects on Phosphoenzyme Formation--
The recombinant
BVP proteins containing mutations in the phosphate-binding motif were
assayed for phosphoenzyme formation during a brief reaction with
[ Conserved Asp60 Is Dispensable for
Catalysis--
Asp60, which is conserved in all of the
metazoan RNA triphosphatases, is located upstream of the
phosphate-binding motif (Fig. 1). A similarly positioned conserved
aspartate side chain of the protein-tyrosine phosphatases and dual
specificity protein phosphatases functions as a general acid catalyst
by donating a proton to the hydroxyamino acid leaving group during the
attack of the cysteine nucleophile on the phosphoprotein substrate.
Consistent with this role in catalysis, mutations of the aspartate
general acid of protein-tyrosine phosphatases, dual specificity protein
phosphatases, and phosphoinositide phosphatases to alanine or
asparagine result in a drastic loss of catalytic power (22, 30-32). To
test the role of Asp60 in the phosphohydrolase reaction of
BVP, we mutated Asp60 to Ala, Asn, and Glu. The purity of
the recombinant D60A, D60N, and D60E proteins was confirmed by SDS-PAGE
(Fig. 7A). The specific ATPase
activities of the D60 mutants were determined by enzyme titration. The
remarkable finding was that the D60A and D60N mutations had virtually
no effect on ATP hydrolysis (Fig. 7B) or the formation of
the [32P]BVP phosphoenzyme (Fig. 7C). We
surmised from this result that hydrolysis of the
An alternative explanation for the nonessentiality of Asp60
is that another aspartate residue in BVP serves as the essential proton
donor to expel ADP. Phylogenetic considerations made us skeptical of
this scenario, insofar as Asp60 is the only aspartic acid
in BVP that is conserved in the seven other metazoan and plant RNA
triphosphatases. Nor are there any glutamate residues of BVP that are
conserved in all of the other proteins. Nonetheless, we tested the
effects on alanine mutation at Asp69 and
Asp101, which are the only other aspartates immediately
upstream of the BVP phosphate-binding motif (Fig. 1). The D69A mutant
was 65% as active as wild-type BVP in ATP hydrolysis, whereas D101A was twice as active as wild-type BVP. Thus, neither Asp60
nor Asp101 is essential for catalysis.
Here we have initiated an analysis of the catalytic mechanism of
BVP, which we regard as a prototype of the metazoan RNA triphosphatase enzyme family that includes the RNA triphosphatase component of the
mRNA capping apparatus. We take advantage of the fact that BVP
(unlike the metazoan capping enzymes) can use nucleoside triphosphates as substrates for We demonstrate formation of a BVP phosphoenzyme and identify the
linkage as a thiophosphate based on its chemical lability. Although we
have not directly mapped the location of the phosphoamino acid, it is
likely that the phosphate is linked to Cys119 because: (i)
replacement of Cys119 by alanine or serine abrogates
phosphoenzyme formation, (ii) of the five cysteines in BVP only
Cys119 is conserved in all of the metazoan RNA
triphosphatases, and (iii) there is definitive evidence that the
equivalent cysteine in protein-tyrosine phosphatases and dual
specificity protein phosphatases acts as the reactive nucleophile (22,
33).
The cysteine thiolate nucleophile is situated within the defining motif
of the cysteine phosphatase superfamily
HCXXGXXR(T/S)G. This motif comprises a
phosphate-binding loop that facilitates catalysis by protein-tyrosine
phosphatases and dual specificity protein phosphatases in two ways. (i)
The backbone amides of the loop interact with the cysteine side chain
and stabilize it as the reactive thiolate in the ground state, and (ii)
the backbone amides and the invariant arginine side chain interact with
the phosphate oxygens to activate the bound substrate for nucleophilic attack and to stabilize the trigonal planar transition state. The
replacement of the catalytic arginine in Yersinia
protein-tyrosine phosphatase by alanine or lysine reduced
kcat by nearly 4 orders of magnitude (34). The
failure of the conservative lysine substitution to appreciably restore
catalytic power is interpreted as a stringent requirement for the
bidentate interaction of two guanidinium nitrogens of this arginine
with the equatorial phosphate oxygens in the transition state (22, 33,
34). This model is in keeping with the 5000-fold decrement in
kcat when the Arg residue of human protein-tyrosine phosphatase 1B was replaced by lysine (31). We find
that Ala substitution of the BVP arginine reduced phosphohydrolase specific activity by at least 3 orders of magnitude, but, unlike the
case of the protein-tyrosine phosphatases, the introduction of a lysine
resulted in the recovery of at least 2 orders of magnitude of catalytic
power to a level of 10% of wild-type activity. Clearly, the bidentate
complex of arginine with the transition state is less critical for BVP
catalysis than it is for protein-tyrosine phosphatase. It is possible
that another side chain of BVP is in contact with the phosphate and
compensates in the transition state for a "second" contact made by
the catalytic arginine of protein-tyrosine phosphatase. Alternatively,
it may simply be the case that BVP does not fully exploit the bidentate
hydrogen-bonding capacity of arginine to accelerate phosphoryl transfer
and therefore a monodentate contact of lysine suffices for 10% of the
full activity.
We find that the conserved histidine immediately preceding the cysteine
nucleophile is essential for catalysis by BVP and that Asn did not
function in lieu of His. Substitution of the equivalent histidine of
Yersinia protein-tyrosine phosphatase by Asn and Ala reduced
kcat by 2 and 3 orders of magnitude,
respectively (35). Replacing the His side chain of human
protein-tyrosine phosphatase 1B by alanine reduced
kcat by 2 orders of magnitude (31). The
conserved histidine side chain participates in a hydrogen bonding
network that serves to stabilize the cysteine thiolate of
protein-tyrosine phosphatase (23). Our mutational data are consistent
with a similar essential function in BVP.
Thr126 is essential for catalysis by BVP and is conserved
as a threonine or serine on the protein-tyrosine phosphatases and dual specificity protein phosphatases. The hydroxyl moiety of the side chain
is necessary and sufficient for BVP function, insofar as activity is
restored when serine in present. Replacing the Thr or Ser residues of
protein-tyrosine phosphatases and dual specificity protein phosphatases
by alanine lowers kcat by at least 2 orders of
magnitude (36-38). The crystal structures of protein-tyrosine phosphatases and dual specificity protein phosphatases reveal that the
O A novel finding was that three other side chains within the conserved
phosphate-binding motif of BVP (Thr120, His121,
and Asn124) and one side chain immediately flanking the
motif (Tyr128) are essential for phosphohydrolase activity.
Structural studies have established that the backbone amide nitrogens
of the phosphate-binding loop form hydrogen bonds to the phosphate
oxygen atoms in the enzyme-substrate complex, the transition state and
the cysteinyl-phosphate intermediate (33), but the roles of the side
chains of the loop (other than those discussed above) have received
little attention because they are not strictly conserved in the
protein-tyrosine phosphatases and dual specificity protein
phosphatases. However, Thr120, His121,
Asn124, and Tyr128 of BVP are tightly conserved
in the other metazoan RNA triphosphatases (Fig. 1). We presume that
these essential side chains either: (i) participate directly in
substrate binding or catalysis (perhaps His121 or
Asn124) or (ii) function indirectly by ensuring the proper
conformation of the loop (Thr120 or Tyr128) in
a manner that is specific to the RNA triphosphatase subfamily of
cysteinyl phosphatases.
A key finding of the present study was that the conserved aspartate of
BVP is dispensable for phosphohydrolase activity and phosphoenzyme
formation. This result is in stark contrast to the essential role of
aspartate in catalysis by other cysteinyl phosphatases. For example, an
alanine substitution of the conserved aspartic acid in human
protein-tyrosine phosphatase 1B decreases kcat
by 5 orders of magnitude (31). Replacing the aspartic acid by
asparagine, which had no significant effect on BVP, reduced the
kcat of Yersinia protein-tyrosine
phosphatase by 3 orders of magnitude (30) and slowed the activity of
the human dual specificity protein phosphatase VHR by 2 orders of
magnitude (22).
A simple explanation for the benign effects of the D60A and D60N
mutations of BVP is that the enzyme is cleaving a phosphoanhydride bond
in which the pKa of ~6.7 for the bridging oxygen of leaving group ADP is sufficiently low that it does not require facilitated expulsion by a proton donor. This is in contrast to the
phosphomonoesterase reactions of protein-tyrosine phosphatases and dual
specificity protein phosphatases, where the serine leaving group has a
pKa of 14 and the tyrosine leaving group has a
pKa of 10. With protein-tyrosine phosphatases and dual specificity protein phosphatases, the leaving group
pKa has little effect on catalysis because its
expulsion is driven by proton donation from the aspartic acid (22, 26).
However, when the Asp is replaced by Asn, the
kcat of the mutant enzyme displays a significant
dependence on leaving group pKa, with reactivity
being enhanced when the pKa is low and impeded when
pKa is high (22). Regulated closure of the general
acid loop of a wild type dual specificity protein phosphatase enzyme is
critical when the pKa of the leaving group is high,
but much less important when the leaving group has a low
pKa (26). To our knowledge, BVP is the first case in
which the presumptive "natural" phosphatase substrate (a
phosphoanhydride) is cleaved efficiently without the aid of a conserved
aspartate general acid.
Finally, it is instructive to compare the mutational effects on BVP to
those reported by Wen et al. (6) for the RNA triphosphatase domain of mammalian mRNA capping enzyme. They found, as did we, that replacing the invariant Arg in the phosphate-binding loop by
alanine abolished triphosphatase activity. However, they reported that
alanine substitutions for conserved residues His125 and
Thr133 in the phosphate-binding loop of mouse RNA
triphosphatase (equivalent to His118 and Thr126
of BVP) elicited only 2-fold reductions in triphosphatase activity (6),
whereas we find that the same changes abrogated the activity of BVP. As
mentioned above, the mutational effects at the His and Thr positions of
BVP are quantitatively in good accord with the mutational data for
protein-tyrosine phosphatases and dual specificity protein
phosphatases. Wen et al. (6) found that an alanine mutation
of the conserved aspartic acid of mammalian capping enzyme reduced its
triphosphatase activity to 10% of the wild-type level. While this
mutation has a greater impact on capping enzyme than BVP, the 10-fold
effect on capping enzyme is much less than the 102 to
105 catalytic decrements incurred by mutations of the
aspartate general acid in protein-tyrosine phosphatases, dual
specificity protein phosphatases, and phosphoinositide phosphatases.
In conclusion, we have highlighted mechanistic similarities between the
virus-encoded RNA triphosphatase BVP and other members of the cysteinyl
phosphatase superfamily, while illuminating structure-function relationships that are unique to BVP. Further mutational and structural analyses of several different members of the RNA triphosphatase subfamily will be required in order to account for their unique specificity in hydrolyzing phosphoanhydride substrates.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Published, JBC Papers in Press, August 22, 2000, DOI 10.1074/jbc.M005748200
The abbreviations used are:
BVP, baculovirus
phosphatase;
PAGE, polyacrylamide gel electrophoresis;
DTT, dithiothreitol.
Mechanism of Phosphoanhydride Cleavage by Baculovirus
Phosphatase*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]ATP
and identify the linkage as a thiophosphate based on its chemical
lability. We surmise that the phosphate is linked to Cys119 of BVP because replacement of
Cys119 by alanine or serine abrogates phosphoenzyme
formation and phosphohydrolase activity. The catalytic cysteine is
situated within a conserved phosphate-binding loop
(118HCTHGINRTGY128). We show that all of the
non-aliphatic side chains of the phosphate-binding loop are
functionally important, insofar as mutants H118A, H121A, N124A, R125A,
T126A, and Y128A were inactive in
phosphate hydrolysis and the
T120A mutant was 7% as active as wild-type BVP. Structure-activity relationships at the essential positions of the phosphate-binding loop
were elucidated by conservative substitutions. A conserved aspartic
acid (Asp60) invoked as a candidate general acid catalyst
was dispensable for phosphohydrolase activity and phosphoenzyme
formation by BVP. We propose that the low pKa of
the bridging oxygen of the
phosphate leaving group circumvents a
requirement for expulsion by a proton donor during attack by cysteine
on the
phosphorus. In contrast, a conserved aspartic acid is
essential for the phosphomonoesterase reactions catalyzed by protein
phosphatases, where the serine or tyrosine leaving groups have a much
higher pKa than does ADP.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
phosphate
of triphosphate-terminated RNA to form a diphosphate end. Two distinct
classes of eukaryotic RNA triphosphatases have been described. The RNA
triphosphatases of metazoans and plants belong to a superfamily of
phosphatases that includes protein-tyrosine phosphatases, dual specificity protein phosphatases, and phosphoinositide phosphatases (1-12). The metazoan RNA triphosphatases do not require a metal cofactor. In contrast, the RNA triphosphatases of fungi and DNA viruses
(poxviruses and baculoviruses), which comprise a new family of
nucleoside triphosphate phosphohydrolases, are strictly dependent on a
divalent cation cofactor (13-19). There are no mechanistic or
structural similarities whatsoever between the metazoan and viral/fungal triphosphatase families (20). Thus, RNA triphosphatase presents a remarkable case of complete divergence during the transition from fungal to metazoan species.
phosphate of triphosphate-terminated poly(A) or the
triphosphate-terminated trinucleotide pppApCpC (10, 11). BPV also
hydrolyzes ATP to ADP and GTP to GDP (10). The remarkable feature of
BVP is that it also catalyzes the hydrolysis of ADP to AMP and GDP to
GMP (10) and the conversion of diphosphate-terminated RNA to
monophosphate-terminated RNA (11). Thus, BVP is a triphosphatase and a diphosphatase. Kinetic analysis of the reaction of BVP
with either triphosphate-terminated RNA or free nucleoside
triphosphates shows that the
phosphate is hydrolyzed prior to the
phosphate and that the enzyme acts distributively, i.e.
that nucleoside monophosphate products do not begin to accumulate until
the majority of the input nucleoside triphosphate has been first
converted to nucleoside diphosphate. Human PIR1, like BVP, is also an
RNA triphosphatase and diphosphatase (12). In contrast, the metazoan capping enzymes hydrolyze only the
phosphate of RNA. Thus, BVP and
PIR1 comprise a functionally distinctive subfamily of cysteinyl phosphatases.

View larger version (30K):
[in a new window]
Fig. 1.
Metazoan RNA triphosphatases. The amino
acid sequence of the baculovirus-encoded RNA triphosphatase BVP from
amino acids 55 to 134 is aligned with human PIR1 and with the sequences
of the N-terminal RNA triphosphatase domains of mouse capping enzyme
(Mus CE), C. elegans capping enzyme
(Cel CE), Drosophila melanogaster capping enzyme
(Dme CE), Xenopus laevis capping enzyme
(Xla CE), and two putative capping enzymes of
Arabidopsis thaliana (Ath CE1 and
CE2). Gaps in the sequences are indicated by
dashes (-). The protein phosphatase signature motif is
highlighted in the shaded box. The active site
cysteine is denoted by an arrow. A conserved Asp residue
located proximal to the signal motif is also shaded. The 12 residues of BVP subjected to mutational analysis are denoted by
asterisks. The reaction pathway through a cysteinyl
phosphate intermediate is shown. For the RNA triphosphatases,
R is a diphosphate-terminated RNA.
-32P]ATP. Suboptimal
reaction conditions, i.e. low temperature and mildly acidic
pH, were required to detect the phosphoenzyme. The lability of the
phosphoenzyme adduct to treatment with iodine was consistent with a
cysteinyl-phosphate adduct. Alanine scanning mutational analysis of the
signature phosphatase motif established essential roles for eight side
chains in
phosphate cleavage. Structure-activity relationships at
the essential positions were then illuminated by conservative
substitutions. A remarkable finding was that the conserved upstream
aspartate was dispensable for the phosphohydrolase activity of BVP.
Mechanistic implications of these results are discussed.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
CE6, which carries the T7 RNA polymerase
gene. Cultures (1 liter) of E. coli BL21/pET16-BVP were
grown at 37 °C in Luria-Bertani medium containing 0.2% maltose and
0.1 mg/ml ampicillin until the A600 reached
0.3-0.4. The cultures were supplemented with 10 mM
MgSO4 and 0.4% glucose, and incubation was continued at
37 °C until the A600 reached ~0.8. The
cultures were chilled on ice for 15 min and then infected by adding
CE6 stock to attain a multiplicity of 5. The cultures were then
incubated for 4 h at 25 °C with continuous shaking, after which
the cells were harvested by centrifugation. The recombinant BVP
proteins were purified from soluble bacterial lysates by nickel-agarose
and phosphocellulose column chromatography as described previously
(10).
-32P]ATP was incubated on ice for 45 s. The
mixture was then made 2% in SDS. Aliquots (1.5 µl) were distributed
to separate tubes and treated with the following reagents in a
total volume of 15 µl: 0.1 M NaOH, 1 M
hydroxylamine (pH 7.0), 0.1 M hydroxylamine (pH 7.0), 1 mM iodine (pH 7.0), 1 M Tris-HCl (pH 7.0), 0.1 M Tris-HCl (pH 7.0). Additional aliquots (1.5 µl) were
pH-adjusted in a total volume of 15 µl of the following solutions: 1 M HCl, 0.1 M HCl, 0.1 M glycine (pH
2.0), 0.1 M Tris formate (pH 3.0), 0.1 M Tris acetate (pH 4.0, 5.0, or 6.0), Tris-HCl (pH 7.0 or 8.0), 0.1 M BTP (pH 9.0 or 10.0), 0.1 M NaOH. The SDS
concentration was maintained at 2% during the chemical treatments. The
mixtures were incubated at 37 °C for 30 min, and the samples were
analyzed by electrophoresis through a 15% polyacrylamide gel
containing 0.1% SDS. (The mixtures in which pH was varied widely from
neutrality were adjusted to neutrality prior to SDS-PAGE). The gels
were soaked for 30 min in a solution of 3% glycerol and 30% methanol
and then dried using the Promega gel-drying kit according to the
vendor's instructions. [32P]BVP adducts were visualized
by autoradiography and quantitated by scanning the gel with a Fujix
BAS2000 phosphorimager.
-32P]ATP, and enzyme were incubated
for 15 min at 30 °C. The reactions were quenched by adding 2.5 µl
of 5 M formic acid. Aliquots of the reaction mixtures were
applied to polyethyleneimine cellulose TLC plates that were developed
in 0.5 M LiCl, 1 M formic acid. [
-32P]ATP and 32Pi were
quantitated by scanning the TLC plate with a phosphorimager.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
phosphate of
triphosphate-terminated RNAs or nucleoside triphosphatases by members
of the cysteine phosphatase superfamily is now well documented, there
has been no direct evidence presented for a phosphoenzyme intermediate analogous to that shown for the protein-tyrosine phosphatases and
dual-specificity protein phosphatases (27, 28). Our initial efforts to
trap a 32P-labeled phosphoenzyme entailed a brief reaction
of 3 µM BVP with 3 µM
[
-32P]ATP, followed by a quench with SDS. The
denatured reaction mixture was analyzed by SDS-PAGE with the
expectation of detecting label transfer from ATP to the BVP
polypeptide. We were unable to detect a phosphoenzyme when the
incubations were performed at 30 °C at pH 7.5 (the optimal
conditions for ATP hydrolysis in the steady state) because the
substrate was hydrolyzed completely to 32Pi
(data not shown). Decreasing the reaction temperature to 4 °C
reduced ATP hydrolysis by BVP by a factor of 18, but did not facilitate
detection of a phosphoenzyme at pH 7.5 (data not shown). We inferred
that hydrolysis of a putative phosphoenzyme intermediate might be much
faster that phosphoryl transfer from ATP when the reactions were
performed at pH 7.5. Thus, we varied the pH of the reaction mixture
from 3.5 to 9.0. Label transfer from [
-32P]ATP to BVP
during a 10-s reaction at 4 °C was detected within a rather narrow
window at mildly acidic pH, with optimal trapping of the phosphoenzyme
in Tris acetate buffer (pH 5.5) (Fig.
2A). No label transfer was
observed when BVP was incubated with [
-32P]ATP (data
not shown). Kinetic analysis of the reaction with [
-32P]ATP at pH 5.5 showed that the phosphoenzyme
accumulated immediately at 10 s, persisted until 2 min, and
decayed from 5 to 30 min (Fig. 2B). The decay of the
radiolabeled phosphoprotein was prevented by adding SDS to the reaction
mixtures after 30 s of reaction with ATP (data not shown). Thus,
the loss of signal did not reflect chemical lability of the
phosphoprotein adduct. The finding that phosphoenzyme formation and ATP
hydrolysis were both abrogated by mutating the Cys119 to
alanine (see below) provided evidence that the phosphoenzyme was
relevant to the catalytic mechanism of BVP.

View larger version (64K):
[in a new window]
Fig. 2.
Formation of a BVP phosphoenzyme.
A, pH dependence. Reaction mixtures (10 µl) containing
containing 3 µM BVP, 3 µM
[
-32P]ATP, 1 mM DTT, and 50 mM
Tris buffer (Tris formate (pH 3.5), Tris acetate (pH 4.0, 4.5, 5.0, 5.5, 6.0, 6.5, or 7.0), or Tris-HCl (pH 7.5, 8.0, 8.5, 9.0)) were
incubated on ice for 10 s and then quenched with 2% SDS. The
samples were analyzed by SDS-PAGE. An autoradiograph of the wet gel is
shown. The positions and sizes (kDa) of pre-stained marker proteins are
indicated on the left. B, kinetics of
phosphoenzyme formation and decay. A reaction mixture containing 50 mM Tris acetate (pH 5.5), 1 mM DTT, 3 µM BVP, and 3 µM [
-32P]ATP
was incubated on ice. Aliquots were removed at the times specified and
quenched immediately with SDS. The samples were analyzed by SDS-PAGE.
An autoradiograph of the wet gel is shown.

View larger version (22K):
[in a new window]
Fig. 3.
Chemical stability of the BVP
phosphoenzyme. A, [32P]BVP was denatured
with SDS and exposed to NaOH, hydroxylamine, or iodine for 30 min at
37 °C. Control samples were exposed to Tris buffer (pH 7.0). The
treated samples were analyzed by SDS-PAGE. An autoradiogram of the
dried gel is shown. B, the pH stability of
[32P]BVP was tested as described under "Experimental
Procedures." Samples incubated for 30 min at the indicated pH were
analyzed by SDS-PAGE, and the levels of 32P label
associated with BVP were quantitated by scanning the dried gel with a
phosphorimager. The data were normalized to the amount of residual
[32P]BVP at pH 10.0 (defined as 100) and plotted as a
function of pH.
-32P]ATP. The extent of ATP hydrolysis was linear
with input enzyme at limiting concentrations, and the reaction
proceeded to completion at saturating enzyme levels (data not shown).
The specific ATPase activities of the BVP-Ala mutants were determined
by enzyme titration. The findings are summarized in Fig.
5, where the ATPase activities of the
mutants are expressed as the percentage of the wild-type specific
activity.

View larger version (27K):
[in a new window]
Fig. 4.
Purification of BVP proteins with mutations
of the phosphate-binding loop. Aliquots (1 µg) of the
phosphocellulose preparations of wild-type (WT) BVP and the
indicated BVP mutants were analyzed by electrophoresis through a 15%
polyacrylamide gel containing 0.1% SDS. Polypeptides were visualized
by staining with Coomassie Blue dye. The positions and sizes (in kDa)
of marker proteins are indicated. A, alanine mutants;
B, conservative mutations.

View larger version (16K):
[in a new window]
Fig. 5.
Effects of phosphate-binding loop mutations
on phosphohydrolase activity and phosphoenzyme formation.
ATPase activity was assayed as described under "Experimental
Procedures." Aliquots (2 µl) of serial 2-fold dilutions of each
phosphocellulose BVP preparation were included in the reaction
mixtures. Between two and four titration experiments were performed for
each protein, and the specific activity was calculated from the average
of the slopes of the titration curves. The ATPase specific activities
shown are normalized to the specific activity of wild type
(WT) BVP (1 pmol of 32Pi released/15
min/ng of protein).
carbon,
but did not reveal the properties of the missing side chain that were
important for activity. This was addressed by introducing conservative
substitutions at the seven newly defined essential residues and at
Cys119, which was shown previously to be essential for BVP
activity (10). The purity of the 15 conservatively substituted
recombinant BVP proteins was confirmed by SDS-PAGE (Fig.
4B). The specific ATPase activities of the conservative
mutants were determined by enzyme titration and are shown in Fig. 5.
The instructive findings are summarized below.
of one of
the two
sites on the threonine/valine side chains. We surmise that
two substituents on the
carbon of amino acid 120 are optimal for
BVP activity. This contrasts with the situation at position 126, where
the T126V mutation was just as deleterious as T126A. However, activity
was restored to 65% of the wild-type level by introducing a serine,
implying that the hydroxyl group is essential for catalysis, presumably
by virtue of its capacity to form a hydrogen bond.
and N
of His, respectively. The
mutational findings at His118 and His121 of BVP
suggested that hydrogen bonding properties of both histidines are
important. Interactions of N
apparently do not suffice for catalysis
at position 118. (We did not construct a H118Q mutant and therefore
cannot draw a conclusion concerning N
). At position 121, both N
and N
appeared to be functionally important.
-32P]ATP at pH 5.5. The reaction products were
analyzed by SDS-PAGE (Fig. 6). There was
good concordance between the mutational effect on steady-state ATP
hydrolysis at pH 7.5 and the yield of phosphoenzyme at pH 5.5. For
example, the conservative mutants T120V, T120S, R125K, T126S, Y128F,
and Y128L that retained ATPase activity were also competent to form the
phosphoenzyme. The mutant proteins that were unable to hydrolyze ATP in
the steady state were also grossly defective in phosphoenzyme
formation. These data provide correlative evidence that the covalent
BVP thiophosphate adduct is a genuine reaction intermediate.

View larger version (31K):
[in a new window]
Fig. 6.
Effects of phosphate-binding loop mutations
on phosphoenzyme formation. Reaction mixtures containing 50 mM Tris acetate (pH 5.5), 1 mM DTT, 3 µM [
-32P]ATP, and 1.7 µM
wild-type (WT) or mutant BVP as specified were incubated on
ice for 10 s. After quenching with SDS, the mixtures were analyzed
by SDS-PAGE. An autoradiogram of the dried gel is shown.
-
phosphoanhydride of ATP by BVP is not limited by the step of expelling
the ADP leaving group. Replacing Asp60 by glutamate
inactivated the enzyme for steady-state ATP hydrolysis and
phosphoenzyme formation (Fig. 7). Thus, although the acidic moiety at
position 60 is not required for catalysis, there is a strong constraint
on the size of the linker arm, such that projection of the carboxylate
away from the main chain by an additional methylene group is
catastrophic for BVP function.

View larger version (23K):
[in a new window]
Fig. 7.
Effects of mutations in the conserved
aspartate. A, aliquots (1 µg) of the phosphocellulose
preparations of wild-type (WT) BVP and the indicated BVP
mutants were electrophoresed through a 15% polyacrylamide gel
containing 0.1% SDS. Polypeptides were visualized by staining with
Coomassie Blue dye. The positions and sizes (in kDa) of marker proteins
are indicated. B, ATPase specific activity and phosphoenzyme
formation were assayed as described in the legend to Fig. 5.
C, phosphoenzyme formation was assayed as described in the
legend to Fig. 6. [32P]BVP was visualized by
autoradiography of the dried gel.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
phosphate cleavage. Thus, we could study BVP and
mutated versions thereof using commercially available nucleoside triphosphates instead of triphosphate-terminated RNAs, which are tedious to prepare. The experiments presented here provide insights into BVP catalysis and reveal interesting mechanistic distinctions between the RNA triphosphatases and the protein phosphatase branches of
the cysteinyl phosphatase superfamily.
of serine or threonine donates a hydrogen bond to the active site
cysteine, an interaction that may stabilize the cysteine thiolate
leaving group during hydrolysis of the phosphoenzyme. The hydrogen bond
between O
and the S
of cysteine is visualized in the transition
state and the cysteinyl-phosphate intermediate (22, 23, 33). Although
it has been reported for protein-tyrosine phosphatases and dual
specificity protein phosphatases that elimination of O
selectively
impedes the hydrolysis reaction of the cysteinyl-phosphate (36, 37), we
did not detect formation of the covalent phosphoenzyme by the T126A
mutant of BVP. Thus, the hydroxyl may play a relatively greater role
the first step of BVP catalysis than it does in the case of
protein-tyrosine phosphatases and dual specificity protein phosphatases. BVP appears similar in its utilization of the catalytic threonine to the mammalian low molecular weight protein-tyrosine phosphatase, in which the equivalent serine is proposed to facilitate attack of the cysteine thiolate on the scissile phosphate (38).
![]()
FOOTNOTES
To whom correspondence should be addressed: Molecular Biology
Program, Sloan-Kettering Inst., 1275 York Ave., New York, NY 10021. E-mail: s-shuman@ski.mskcc.org.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Takagi, T.,
Moore, C. R.,
Diehn, F.,
and Buratowski, S.
(1997)
Cell
89,
867-873
2.
Wang, S. P.,
Deng, L.,
Ho, C. K.,
and Shuman, S.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
9573-9578
3.
McCracken, S.,
Fong, N.,
Rosonina, E.,
Yankulov, K.,
Brothers, G.,
Siderovski, D.,
Hessel, A.,
Foster, S.,
Shuman, S.,
and Bentley, D. L.
(1997)
Genes Dev.
11,
3306-3318
4.
Ho, C. K.,
Sriskanda, V.,
McCracken, S.,
Bentley, D.,
Schwer, B.,
and Shuman, S.
(1998)
J. Biol. Chem.
273,
9577-9585
5.
Yue, Z.,
Maldonado, E.,
Pillutla, R.,
Cho, H.,
Reinberg, D.,
and Shatkin, A. J.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
12898-12903
6.
Wen, Y.,
Yue, Z.,
and Shatkin, A. J.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
12226-12231
7.
Yamada-Okabe, T.,
Doi, R.,
Shimmi, O.,
Arisawa, M.,
and Yamada-Okabe, H.
(1998)
Nucleic Acids Res.
26,
1700-1706
8.
Tsukamoto, T.,
Shibagaki, Y.,
Murakoshi, T.,
Suzuki, M.,
Nakamura, A.,
Gotoh, H.,
and Mizumoto, K.
(1998)
Biochem. Biophys. Res. Commun.
243,
101-108
9.
Yokoska, J.,
Tsukamoto, T.,
Miura, K.,
Shiokawa, K.,
and Mizumoto, K.
(2000)
Biochem. Biophys. Res. Commun.
268,
617-624
10.
Gross, C. H.,
and Shuman, S.
(1998)
J. Virol.
72,
7057-7063
11.
Takagi, T.,
Hao, L.,
Charbonneau, H.,
and Buratowski, S.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
9808-9812
12.
Deshpande, T.,
Takagi, T.,
Hao, L.,
Buratowski, S.,
and Charbonneau, H.
(1999)
J. Biol. Chem.
274,
16590-16594
13.
Ho, C. K.,
Pei, Y.,
and Shuman, S.
(1998)
J. Biol. Chem.
273,
34151-34156
14.
Pei, Y.,
Ho, C. K.,
Schwer, B.,
and Shuman, S.
(1999)
J. Biol. Chem.
274,
28865-28874
15.
Rodriguez, C. R.,
Takagi, T.,
Cho, E.,
and Buratowski, S.
(1999)
Nucleic Acids Res.
27,
2182-2188
16.
Pei, Y.,
Lehman, K.,
Tian, L.,
and Shuman, S.
(2000)
Nucleic Acids Res.
28,
1885-1892
17.
Yu, L.,
Martins, A.,
Deng, L.,
and Shuman, S.
(1997)
J. Virol.
71,
9837-9843
18.
Gross, C. H.,
and Shuman, S.
(1998)
J. Virol.
72,
10020-10028
19.
Jin, J.,
Dong, W.,
and Guarino, L. A.
(1998)
J. Virol.
72,
10011-10019
20.
Lima, C.,
Wang, L. K.,
and Shuman, S.
(1999)
Cell
99,
533-543
21.
Denu, J. M.,
and Dixon, J. E.
(1998)
Curr. Opin. Chem. Biol.
2,
633-641
22.
Denu, J. M.,
Lohse, D. L.,
Vijayalakshmi, J.,
Saper, M. A.,
and Dixon, J. E.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
2493-2498
23.
Stuckey, J. A.,
Schubert, H. L.,
Fauman, E. B.,
Zhang, Z. Y.,
Dixon, J. E.,
and Saper, M. A.
(1994)
Nature
370,
571-575
24.
Jia, Z.,
Barford, D.,
Flint, A. J.,
and Tonks, N. K.
(1995)
Science
268,
1754-1758
25.
Stewart, A. E.,
Dowd, S.,
Keyse, S. M.,
and McDonald, N. Q.
(1999)
Nat. Struct. Biol.
6,
174-181
26.
Fjeld, C. C.,
Rice, A.,
Kim, Y.,
Gee, K. R.,
and Denu, J. M.
(2000)
J. Biol. Chem.
275,
6749-6757
27.
Guan, K. L.,
and Dixon, J. E.
(1991)
J. Biol. Chem.
266,
17026-17030
28.
Zhou, G.,
Denu, J. M.,
Wu, L.,
and Dixon, J. E.
(1994)
J. Biol. Chem.
269,
28084-28090
29.
Herr, E. B.,
and Koshland, D. E.
(1957)
Biochim. Biophys. Acta
25,
219-220
30.
Zhang, Z. Y.,
Wang, Y.,
and Dixon, J. E.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
1624-1627
31.
Flint, A. J.,
Tiganis, T.,
Barford, D.,
and Tonks, N. K.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
1680-1685
32.
Lee, J. O.,
Yang, H.,
Georgescu, M. M.,
DiCristofano, A.,
Maehama, T.,
Sihi, Y.,
Dixon, J. E.,
Pandolfi, P.,
and Pavletich, N. P.
(1999)
Cell
99,
323-334
33.
Pannifer, A. D. B.,
Flint, A. J.,
Tonks, N. K.,
and Barford, D.
(1998)
J. Biol. Chem.
273,
10454-10462
34.
Zhang, Z. Y.,
Wang, Y.,
Wu, L.,
Fauman, E. B.,
Stuckey, J. A.,
Schubert, H. L.,
Saper, M. A.,
and Dixon, J. E.
(1994)
Biochemistry
33,
15266-15270
35.
Zhang, Z. Y.,
and Dixon, J. E.
(1993)
Biochemistry
32,
9340-9345
36.
Denu, J. M.,
and Dixon, J. E.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
5910-5914
37.
Lohse, D. L.,
Denu, J. M.,
Santoro, N.,
and Dixon, J. E.
(1997)
Biochemistry
36,
4568-4575
38.
Evans, B.,
Tishmack, P. A.,
Pokalsky, C.,
Zhang, M.,
and Van Etten, R. L.
(1995)
Biochemistry
35,
13609-13617
39.
Ho, S. N.,
Hunt, H. D.,
Horton, R. M.,
Pullen, J. K.,
and Pease, L. R.
(1989)
Gene (Amst.)
77,
51-59
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. F. Souliere, J.-P. Perreault, and M. Bisaillon Magnesium-binding studies reveal fundamental differences between closely related RNA triphosphatases Nucleic Acids Res., February 2, 2008; 36(2): 451 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Changela, A. Martins, S. Shuman, and A. Mondragon Crystal Structure of Baculovirus RNA Triphosphatase Complexed with Phosphate J. Biol. Chem., May 6, 2005; 280(18): 17848 - 17856. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takagi, A. K. Walker, C. Sawa, F. Diehn, Y. Takase, T. K. Blackwell, and S. Buratowski The Caenorhabditis elegans mRNA 5'-Capping Enzyme. IN VITRO AND IN VIVO CHARACTERIZATION J. Biol. Chem., April 11, 2003; 278(16): 14174 - 14184. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Ho, C. Gong, and S. Shuman RNA Triphosphatase Component of the mRNA Capping Apparatus of Paramecium bursaria Chlorella Virus 1 J. Virol., February 15, 2001; 75(4): 1744 - 1750. [Abstract] [Full Text] |
||||
![]() |
Y. Pei, B. Schwer, S. Hausmann, and S. Shuman Characterization of Schizosaccharomyces pombe RNA triphosphatase Nucleic Acids Res., January 15, 2001; 29(2): 387 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bisaillon and S. Shuman Structure-Function Analysis of the Active Site Tunnel of Yeast RNA Triphosphatase J. Biol. Chem., May 11, 2001; 276(20): 17261 - 17266. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||